CORONAVIRUS/Medigen to hold small Phase 3 trial of its COVID-19 vaccine in Paraguay

07/20/2021 07:01 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, July 20 (CNA) Medigen Vaccine Biologics Corp. announced Tuesday that it has received permission to hold a 1,000-person Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, which was granted emergency use authorization (EUA) in Taiwan the day before.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.